Replies to post #27946 on BioCurex, Inc.(fka BOCX)

[Gold Seeker]

Opportunity, last year, you made a comparison of BioCurex to Radient Pharmaceuticals in what can happen to the stock price.

Now, you should have learned that Radient Pharmaceuticals was lying in press releases and is being sued by two firms for shareholder fraud.

[tentacle]

I agree completely with Opportunity. The synthetic formulation work and its rationale is interesting, but we should have been informed some time ago that that was the reason Oncopet was held up ... again (just like they should have told us early on about the liability issue holding it up in previous quarters).

The value Burger could have brought to this organization is improved communication. We get hints of it, but he hasn't done what he has promised.

The board needs a good shake.